InspireMD Inc
XBER:II2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InspireMD Inc
XBER:II2
|
IL |
|
Artelo Biosciences Inc
NASDAQ:ARTL
|
US |
|
Heron Resources Ltd
ASX:HRR
|
AU |
Wall Street
Price Targets
II2 Price Targets Summary
InspireMD Inc
According to Wall Street analysts, the average 1-year price target for
II2
is 22.074 EUR
with a low forecast of 17.486 EUR and a high forecast of 27.267 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is II2's stock price target?
Price Target
22.074
EUR
According to Wall Street analysts, the average 1-year price target for
II2
is 22.074 EUR
with a low forecast of 17.486 EUR and a high forecast of 27.267 EUR.
What is InspireMD Inc's Revenue forecast?
Projected CAGR
58%
For the last 12 years the
compound annual growth rate for
InspireMD Inc's revenue is
3%.
The projected
CAGR
for the next 3 years is
58%.
